{"id":"https://openalex.org/W4361815440","doi":"https://doi.org/10.1158/0008-5472.c.6507687","title":"Data from Dynamic Patterns of Clonal Evolution in Tumor Vasculature Underlie Alterations in Lymphocyte\u2013Endothelial Recognition to Foster Tumor Immune Escape","display_name":"Data from Dynamic Patterns of Clonal Evolution in Tumor Vasculature Underlie Alterations in Lymphocyte\u2013Endothelial Recognition to Foster Tumor Immune Escape","publication_year":2023,"publication_date":"2023-03-30","ids":{"openalex":"https://openalex.org/W4361815440","doi":"https://doi.org/10.1158/0008-5472.c.6507687"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.6507687","doi":"https://doi.org/10.1158/0008-5472.c.6507687","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6507687","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/0008-5472.c.6507687","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084543688","display_name":"Daniel M. Corey","orcid":"https://orcid.org/0009-0006-4347-4646","observed_orcids":["https://orcid.org/0009-0006-4347-4646"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel M. Corey","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027977934","display_name":"Yuval Rinkevich","orcid":"https://orcid.org/0000-0003-3658-0257","observed_orcids":["https://orcid.org/0000-0003-3658-0257","https://orcid.org/0000-0001-6290-7271"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuval Rinkevich","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5082894731","display_name":"Irving L. Weissman","orcid":"https://orcid.org/0000-0002-9077-7467","observed_orcids":["https://orcid.org/0000-0002-9077-7467"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Irving L. Weissman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.004999999888241291,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-vasculature","display_name":"tumor vasculature","score":0.9070000052452087},{"id":"https://openalex.org/keywords/clonal-evolution","display_name":"clonal evolution","score":0.9869999885559082},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.652999997138977},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8999999761581421},{"id":"https://openalex.org/keywords/founder-clone","display_name":"founder clone","score":0.6660000085830688},{"id":"https://openalex.org/keywords/subclonal-expansion","display_name":"subclonal expansion","score":0.546999990940094},{"id":"https://openalex.org/keywords/tumor-immune-evasion","display_name":"tumor immune evasion","score":0.7710000276565552},{"id":"https://openalex.org/keywords/madcam-1","display_name":"MAdCAM-1","score":0.8759999871253967},{"id":"https://openalex.org/keywords/lymphocyte-homing","display_name":"lymphocyte homing","score":0.9259999990463257},{"id":"https://openalex.org/keywords/chemokines","display_name":"chemokines","score":0.8679999709129333},{"id":"https://openalex.org/keywords/hgf-c-met-signaling","display_name":"HGF/MET signaling","score":0.906000018119812},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.8370000123977661},{"id":"https://openalex.org/keywords/platelet-derived-growth-factor","display_name":"platelet-derived growth factor","score":0.996999979019165},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.7950000166893005},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy-resistance","display_name":"anti-angiogenic therapy resistance","score":0.8370000123977661}],"concepts":[{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.728878915309906},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.6696720719337463},{"id":"https://openalex.org/C4175445","wikidata":"https://www.wikidata.org/wiki/Q14907568","display_name":"Addressin","level":4,"score":0.5723551511764526},{"id":"https://openalex.org/C128240485","wikidata":"https://www.wikidata.org/wiki/Q786998","display_name":"Autocrine signalling","level":3,"score":0.5330312252044678},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5281674265861511},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.5184692740440369},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5091962218284607},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.47728171944618225},{"id":"https://openalex.org/C7876069","wikidata":"https://www.wikidata.org/wiki/Q14873666","display_name":"Paracrine signalling","level":3,"score":0.46554645895957947},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.4475496709346771},{"id":"https://openalex.org/C2780385752","wikidata":"https://www.wikidata.org/wiki/Q637997","display_name":"High endothelial venules","level":3,"score":0.4354771375656128},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.43100059032440186},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2774164080619812},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2088722586631775},{"id":"https://openalex.org/C195687474","wikidata":"https://www.wikidata.org/wiki/Q409715","display_name":"Integrin","level":3,"score":0.19351890683174133},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1627173125743866}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.c.6507687","doi":"https://doi.org/10.1158/0008-5472.c.6507687","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6507687","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.6507687","doi":"https://doi.org/10.1158/0008-5472.c.6507687","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6507687","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2221476631","https://openalex.org/W1979614911","https://openalex.org/W2511835027","https://openalex.org/W28532689","https://openalex.org/W7100055729","https://openalex.org/W2914619843","https://openalex.org/W4361824883","https://openalex.org/W2061102473","https://openalex.org/W4389210584","https://openalex.org/W2956003277"],"abstract_inverted_index":{"Abstract":[0],"Although":[1],"tumor":[2,23,38,43,57,63,153,180,208,225],"blood":[3,44,91],"vessels":[4,45,92],"have":[5,211],"been":[6],"a":[7,28,47,69,96,100,139,213],"major":[8],"therapeutic":[9],"target":[10],"for":[11,115],"cancer":[12],"chemotherapy,":[13],"little":[14],"is":[15],"known":[16],"regarding":[17],"the":[18,22,37,59,143,157,162,203],"stepwise":[19],"development":[20],"of":[21,49,62,119,145,161,189],"microenvironment.":[24],"Here,":[25],"we":[26,137],"use":[27],"multicolor":[29],"Cre-dependent":[30],"marker":[31],"system":[32],"to":[33,40,99],"trace":[34],"clonality":[35],"within":[36,207],"microenvironment":[39],"show":[41,138],"that":[42,221],"follow":[46],"pattern":[48],"dynamic":[50],"clonal":[51],"evolution.":[52],"In":[53],"an":[54],"advanced":[55],"melanoma":[56],"microenvironment,":[58],"vast":[60],"majority":[61],"vasculature":[64],"clones":[65,77],"are":[66,82,93,183],"derived":[67],"from":[68,232],"common":[70],"precursor.":[71],"Quantitative":[72],"lineage":[73],"analysis":[74,112],"reveals":[75,113],"founder":[76],"diminish":[78],"in":[79,142,159,176,187,202],"frequency":[80],"and":[81,103,110,128,134,197,215,228],"replaced":[83],"by":[84,95,185],"subclones":[85,182],"as":[86,124,156],"tumors":[87],"evolve.":[88],"These":[89,199],"tumor-specific":[90],"characterized":[94],"developmental":[97,140],"switch":[98,141],"more":[101],"invasive":[102],"immunologically":[104],"silent":[105],"phenotype.":[106],"Gene":[107],"expression":[108,144,160,188],"profiling":[109],"pathway":[111],"selection":[114],"traits":[116],"promoting":[117],"upregulation":[118],"alternative":[120],"angiogenic":[121],"programs":[122],"such":[123,155],"unregulated":[125],"HGF-MET":[126],"signaling":[127,131],"enhanced":[129],"autocrine":[130],"through":[132],"VEGF":[133],"PDGF.":[135],"Furthermore,":[136],"functionally":[146],"significant":[147],"primary":[148],"lymphocyte":[149,173,190,219],"adhesion":[150],"molecules":[151],"on":[152,170,179,218],"endothelium,":[154],"loss":[158],"mucosal":[163],"addressin":[164],"MAdCAM-1,":[165],"whose":[166],"counter":[167],"receptor":[168],"a4\u03b27":[169],"lymphocytes":[171],"controls":[172],"homing.":[174],"Changes":[175],"adhesive":[177],"properties":[178],"endothelial":[181],"accompanied":[184],"decreases":[186],"chemokines":[191],"CXCL16,":[192],"CXCL13,":[193],"CXCL12,":[194],"CXCL9,":[195],"CXCL10,":[196],"CCL19.":[198],"evolutionary":[200],"patterns":[201],"expressed":[204],"genetic":[205],"program":[206],"endothelium":[209],"will":[210],"both":[212],"quantitative":[214],"functional":[216],"impact":[217],"distribution":[220],"may":[222],"well":[223],"influence":[224],"immune":[226],"function":[227],"underlie":[229],"escape":[230],"mechanisms":[231],"current":[233],"antiangiogenic":[234],"pharmacotherapies.":[235],"Cancer":[236],"Res;":[237],"76(6);":[238],"1348\u201353.":[239],"\u00a92015":[240],"AACR.":[241]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2023-04-05T00:00:00"}